Central lymph node ratio is an important recurrence prognostic factor for pediatric differentiated thyroid cancer

• Published in: Frontiers in endocrinology (Lausanne) Vol. 15; p. 1290617
• Main Authors: Qiu, Caixin, Wu, Shipeng, Li, Jiehua
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 02.07.2024
• Subjects: Adolescent; Child; Child, Preschool; Endocrinology; Female; Follow-Up Studies; Humans; Lymph Node Ratio; Lymph Nodes - pathology; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local - epidemiology; Neoplasm Recurrence, Local - pathology; pediatric; Prognosis; recurrence; Retrospective Studies; risk stratification; thyroid cancer; Thyroid Neoplasms - mortality; Thyroid Neoplasms - pathology; Thyroidectomy; Young Adult; recurrence; lymph node ratio; thyroid cancer; risk stratification; pediatric
• ISSN: 1664-2392; 1664-2392
• DOI: 10.3389/fendo.2024.1290617

The current risk stratification methods for Pediatric Differentiated Thyroid Carcinoma (DTC) are deemed inadequate due to the high recurrence rates observed in this demographic. This study investigates alternative clinicopathological factors, specifically the Central Lymph Node Ratio (CLNR), for improved risk stratification in pediatric DTC. A retrospective review of 100 pediatric DTC patients, aged 19 or younger, treated between December 2012 and January 2021 at the First Affiliated Hospital of Guangxi Medical University was conducted. Clinicopathological variables were extracted, and univariate logistic regression identified factors correlated with recurrence. Kaplan-Meier (KM) survival analysis and subsequent statistical tests were used to assess the significance of these factors. The CLNR, with a cutoff value of 77.78%, emerged as a significant predictor of recurrence. Patients with a CLNR above this threshold had a 5.467 times higher risk of recurrence. The high CLNR group showed a higher proportion of male patients, clinically lymph node positivity (cN1), and extrathyroidal extension (ETE) compared to the low-risk group (p<0.05). CLNR is a valuable predictor for recurrence in pediatric DTC and aids in stratifying patients based on Recurrence-Free Survival (RFS). For patients with a high CLNR, aggressive iodine-131 therapy, stringent TSH suppression, and proactive postoperative surveillance are recommended to mitigate recurrence risk and facilitate timely detection of recurrent lesions.